These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19319670)

  • 1. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo.
    Ren T; Xu L; Jiao S; Wang Y; Cai Y; Liang Y; Zhou Y; Zhou H; Wen Z
    Pathol Oncol Res; 2009 Dec; 15(4):623-30. PubMed ID: 19319670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.
    Ren T; Wen ZK; Liu ZM; Liang YJ; Guo ZL; Xu L
    Cancer Biol Ther; 2007 Nov; 6(11):1704-9. PubMed ID: 17986857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell.
    Xu L; Wang C; Wen Z; Yao X; Liu Z; Li Q; Wu Z; Xu Z; Liang Y; Ren T
    Immunol Lett; 2010 Jan; 127(2):93-9. PubMed ID: 19854217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell.
    Xu L; Zhou Y; Liu Q; Luo JM; Qing M; Tang XY; Yao XS; Wang CH; Wen ZK
    Biochem Biophys Res Commun; 2009 May; 382(3):571-6. PubMed ID: 19302975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9.
    Zhang Y; Lin A; Zhang C; Tian Z; Zhang J
    Cancer Immunol Immunother; 2014 Apr; 63(4):357-67. PubMed ID: 24452201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
    Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells.
    Wang C; Fei G; Liu Z; Li Q; Xu Z; Ren T
    Cancer Biol Ther; 2012 Jul; 13(9):727-36. PubMed ID: 22617774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer.
    Li Q; Li X; Guo Z; Xu F; Xia J; Liu Z; Ren T
    PLoS One; 2012; 7(11):e48278. PubMed ID: 23133627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.
    Zhang Y; Lin A; Sui Q; Zhang C; Tian Z; Zhang J
    Cancer Lett; 2014 Dec; 355(1):76-84. PubMed ID: 25224571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway.
    Xu L; Wen Z; Zhou Y; Liu Z; Li Q; Fei G; Luo J; Ren T
    Mol Biol Cell; 2013 Jan; 24(1):42-55. PubMed ID: 23135998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lung cancer cells express functionally active Toll-like receptor 9.
    Droemann D; Albrecht D; Gerdes J; Ulmer AJ; Branscheid D; Vollmer E; Dalhoff K; Zabel P; Goldmann T
    Respir Res; 2005 Jan; 6(1):1. PubMed ID: 15631627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.
    Brignole C; Marimpietri D; Di Paolo D; Perri P; Morandi F; Pastorino F; Zorzoli A; Pagnan G; Loi M; Caffa I; Erminio G; Haupt R; Gambini C; Pistoia V; Ponzoni M
    Cancer Res; 2010 Dec; 70(23):9816-26. PubMed ID: 20935225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo.
    Knuefermann P; Baumgarten G; Koch A; Schwederski M; Velten M; Ehrentraut H; Mersmann J; Meyer R; Hoeft A; Zacharowski K; Grohé C
    Respir Res; 2007 Oct; 8(1):72. PubMed ID: 17925007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFR
    Wang G; Zhao J; Zhang M; Wang Q; Chen B; Hou Y; Lu K
    Int J Nanomedicine; 2019; 14():4503-4515. PubMed ID: 31417255
    [No Abstract]   [Full Text] [Related]  

  • 19. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.